BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6929726)

  • 21. Gleditsia sinensis fruit extract is a potential chemotherapeutic agent in chronic and acute myelogenous leukemia.
    Chow LM; Chui CH; Tang JC; Teo IT; Lau FY; Cheng GY; Wong RS; Leung TW; Lai KB; Yau MY; Gou D; Chan AS
    Oncol Rep; 2003; 10(5):1601-7. PubMed ID: 12883747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of flt3 ligand on in vitro growth and expansion of colony-forming bone marrow cells from patients with aplastic anemia.
    Wodnar-Filipowicz A; Chklovskaia E; Manz CY; Lyman SD; Nissen C
    Exp Hematol; 1997 Jul; 25(7):573-81. PubMed ID: 9216732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of deoxycytidine on 2-chloro-deoxyadenosine-mediated growth inhibition of normal human erythroid and myeloid progenitor cells.
    Bilgeri R; Petzer AL; Zilian U; Geisen FH; Schirmer M; Haun M; Konwalinka G
    Exp Hematol; 1993 Mar; 21(3):432-7. PubMed ID: 8095026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapeutic sensitivity of normal and leukemic hematopoietic progenitor cells to N-[4-(9-acridinylamino)-3-methoxyphenyl]-methanesulfonamide, a new anticancer agent.
    Spiro TE; Socquet M; Delforge A; Stryckmans P
    J Natl Cancer Inst; 1981 Apr; 66(4):615-8. PubMed ID: 6939909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth of sensitive and drug-resistant human myeloid leukemia cells in SCID mice.
    Beran M; Pisa P; Kantarjian H; Porwit A; Bjorkholm M
    Hematol Pathol; 1994; 8(4):135-54. PubMed ID: 7860433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone marrow fibroblast exposure to the inflammatory cytokines tumor necrosis factor-alpha and interferon-gamma increases adhesion of acute myeloid leukemia cells and alters the adhesive mechanism.
    Bendall LJ; Kortlepel K; Gottlieb DJ
    Exp Hematol; 1997 Feb; 25(2):132-9. PubMed ID: 9015213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiation sensitivity of leukemic progenitor cells in acute nonlymphocytic leukemia.
    Ozawa K; Miura Y; Suda T; Motoyoshi K; Takaku F
    Cancer Res; 1983 May; 43(5):2339-41. PubMed ID: 6339049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of stem cell factor on irradiated human bone marrow.
    Leigh BR; Hancock SL; Knox SJ
    Cancer Res; 1993 Sep; 53(17):3857-9. PubMed ID: 7689418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Divergent regulation of 1,25-dihydroxyvitamin D3 on human bone marrow osteoclastogenesis and myelopoiesis.
    Qi DY; Perkins SL; Kling SJ; Russell RG
    J Cell Biochem; 1999 Mar; 72(3):387-95. PubMed ID: 10022520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and validation of a clinically applicable culture procedure for the generation of interleukin-2 activated natural killer cells in human bone marrow autografts.
    Klingemann HG; Deal H; Reid D; Eaves CJ
    Exp Hematol; 1993 Aug; 21(9):1263-70. PubMed ID: 8330650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective destruction of human leukemic cells by alkyl-lysophospholipids.
    Andreesen R; Modolell M; Weltzien HU; Eibl H; Common HH; Löhr GW; Munder PG
    Cancer Res; 1978 Nov; 38(11 Pt 1):3894-9. PubMed ID: 279399
    [No Abstract]   [Full Text] [Related]  

  • 32. The membrane-bound isoform of stem cell factor synergizes with soluble flt3 ligand in supporting early hematopoietic cells in long-term cultures of normal and aplastic anemia bone marrow.
    Slanicka Krieger M; Nissen C; Manz CY; Toksoz D; Lyman SD; Wodnar-Filipowicz A
    Exp Hematol; 1998 May; 26(5):365-73. PubMed ID: 9590652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential sensitivity to cryopreservation of clonogenic progenitor cells and stromal precursors from leukemic and normal bone marrow.
    Zaheer HA; Gibson FM; Bagnara M; Gordon-Smith EC; Rutherford TR
    Stem Cells; 1994 Mar; 12(2):180-6. PubMed ID: 8199561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective toxicity of 6-hydroxydopamine and ascorbate for human neuroblastoma in vitro: a model for clearing marrow prior to autologous transplant.
    Reynolds CP; Reynolds DA; Frenkel EP; Smith RG
    Cancer Res; 1982 Apr; 42(4):1331-6. PubMed ID: 7037175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro drug sensitivity studies of CFUc in chronic myelocytic leukemia: I. Suicide indices and busulfan sensitivity determinations during the chronic phase.
    Preisler HD; Kirshner J
    Exp Hematol; 1983 Aug; 11(7):618-25. PubMed ID: 6576910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of alkyl-lysophospholipids on tritiated thymidine incorporation and clonogenicity in vitro of normal and leukemic human cells.
    Vogler WR; Whigham EA; Somberg LB; Long RC; Winton EF
    Exp Hematol; 1984 Aug; 12(7):569-74. PubMed ID: 6540197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro growth of normal and leukemic human bone marrow.
    Brown CH; Carbone PP
    J Natl Cancer Inst; 1971 May; 46(5):989-1000. PubMed ID: 5290566
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of bone marrow stromal cells on the cloning of human leukemia/lymphoma cell lines.
    Seshadri R; Matthews C; Gardiakos C; Morley AA
    Int J Cell Cloning; 1984 Sep; 2(5):277-85. PubMed ID: 6491390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro cytotoxic drug sensitivity of human normal and malignant lymphocyte-clone-forming cells.
    Matthews C; Kutlaca B; Seshadri R
    Int J Cell Cloning; 1987 Mar; 5(2):149-57. PubMed ID: 3471818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective lethal effect of thymidine on human and mouse tumor cells.
    Lee SS; Giovanella BC; Stehlin JS
    J Cell Physiol; 1977 Sep; 92(3):401-5. PubMed ID: 903380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.